Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Fujio

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Neurologia Medico-Chirurgica|August 29, 2017
Preoperative and Postoperative Pituitary Function in Patients with Tuberculum Sellae Meningioma -Based on Pituitary Provocation TestsShingo Fujio, Hirofumi Hirano, Mami Yamashita, et al.
Cancers|August 7, 2021
Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen ContentKiyohisa Kamimura, Masanori Nakajo, Manisha Bohara, et al.
Surgical Neurology International|March 12, 2024
Secondary hypophysitis associated with Rathke's cleft cyst resembling a pituitary abscessEri Inoue, Irfan Kesumayadi, Shingo Fujio, et al.
Endocrine Journal|March 11, 2021
Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in JapanAkira Shimatsu, Akinobu Nakamura, Yutaka Takahashi, et al.
Acta Neurochirurgica|August 20, 2021
Dural sac shrinkage signs on magnetic resonance imaging at the thoracic level in spontaneous intracranial hypotension-its clinical significanceTakashi Kawahara, Kazunori Arita, Shingo Fujio, et al.
Brain Tumor Pathology|June 11, 2013
Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostainingHirofumi Hirano, Hajime Yonezawa, Shunji Yunoue, et al.
Neurologia Medico-Chirurgica|August 28, 2022
Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene PanelNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 15, 2012
TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6Hirofumi Hirano, Takako Yoshioka, Shunji Yunoue, et al.
Neurologia Medico-Chirurgica|May 10, 2021
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot MutationsShingo Fujio, Tareq A Juratli, Tomoko Takajo, et al.
Neuro-Oncology Advances|September 25, 2023
Alterations in <i>EGFR</i> and <i>PDGFRA</i> are associated with the localization of contrast-enhancing lesions in glioblastomaRyutaro Makino, Nayuta Higa, Toshiaki Akahane, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Neurologia Medico-Chirurgica|August 29, 2017
Preoperative and Postoperative Pituitary Function in Patients with Tuberculum Sellae Meningioma -Based on Pituitary Provocation TestsShingo Fujio, Hirofumi Hirano, Mami Yamashita, et al.
Cancers|August 7, 2021
Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen ContentKiyohisa Kamimura, Masanori Nakajo, Manisha Bohara, et al.
Surgical Neurology International|March 12, 2024
Secondary hypophysitis associated with Rathke's cleft cyst resembling a pituitary abscessEri Inoue, Irfan Kesumayadi, Shingo Fujio, et al.
Endocrine Journal|March 11, 2021
Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in JapanAkira Shimatsu, Akinobu Nakamura, Yutaka Takahashi, et al.
Acta Neurochirurgica|August 20, 2021
Dural sac shrinkage signs on magnetic resonance imaging at the thoracic level in spontaneous intracranial hypotension-its clinical significanceTakashi Kawahara, Kazunori Arita, Shingo Fujio, et al.
Brain Tumor Pathology|June 11, 2013
Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostainingHirofumi Hirano, Hajime Yonezawa, Shunji Yunoue, et al.
Neurologia Medico-Chirurgica|August 28, 2022
Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene PanelNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 15, 2012
TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6Hirofumi Hirano, Takako Yoshioka, Shunji Yunoue, et al.
Neurologia Medico-Chirurgica|May 10, 2021
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot MutationsShingo Fujio, Tareq A Juratli, Tomoko Takajo, et al.
Neuro-Oncology Advances|September 25, 2023
Alterations in <i>EGFR</i> and <i>PDGFRA</i> are associated with the localization of contrast-enhancing lesions in glioblastomaRyutaro Makino, Nayuta Higa, Toshiaki Akahane, et al.
Pageof 8